Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jing,Ni

第一单位： Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

作者： Jing,Ni ^[1] ; Junjie,Zhou ^[2] ; Zhangbiao,Long ^[1] ; Xin,Chen ^[1] ; Xiaowen,Chen ^[1] ; Jian,Hong ^[1] ; Xinglin,Liang ^[1] ; Qingsheng,Li ^[1] ; Ruixiang,Xia ^[1] ; Jian,Ge ^[1]

作者单位： Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. ^[1] Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China. ^[2]

关键词 chimeric antigen receptor T cell donor cell-derived leukemia durable complete remission interferon-α post-transplant recurrence

DOI 10.3389/fonc.2022.1021786

PMID 36505803

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

1021786页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除